Opioid-induced Constipation Market Report

Europe Opioid-induced Constipation Market Size, Status and Forecast 2014-2026

  • POSTDATE：Dec 23, 2019
  • PAGES：154
  • REPORT CODE：GMM409206
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Opioid-induced Constipation market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 8.4% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Opioid-induced Constipation Market Segmentations:

    By Player:

    • Theravance

    • Synergy Pharmaceuticals

    • Abbott

    • AstraZeneca

    • Cosmo Pharmaceuticals

    • Progenics Pharmaceuticals

    • Mundipharma

    • Boehringer Ingelheim

    • Sucampo

    • Ironwood Pharmaceuticals

    • Takeda Pharmaceutical

    • Pfizer

    • Shionogi

    • Daiichi Sankyo

    • GlaxoSmithKline

    • Johnson & Johnson

    • Nektar Therapeutics

    • Valeant Pharmaceuticals International

    • Merck

    • SLA Pharma

    • Daewoong

    • Bayer

    By Type:

    • Solid

    • Liquid

    By End-User:

    • Drugstore

    • Hospital

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Opioid-induced Constipation Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Opioid-induced Constipation Market Size and Growth Rate of Solid from 2014 to 2026

    • 1.3.2 Europe Opioid-induced Constipation Market Size and Growth Rate of Liquid from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Opioid-induced Constipation Market Size and Growth Rate of Drugstore from 2014 to 2026

    • 1.4.2 Europe Opioid-induced Constipation Market Size and Growth Rate of Hospital from 2014 to 2026

    • 1.4.3 Europe Opioid-induced Constipation Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Opioid-induced Constipation Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Opioid-induced Constipation by Major Types

      • 3.4.1 Market Size and Growth Rate of Solid

      • 3.4.2 Market Size and Growth Rate of Liquid

    4 Segmentation of Opioid-induced Constipation Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Opioid-induced Constipation by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Opioid-induced Constipation for Drugstore

      • 4.4.2 Market Size and Growth Rate of Opioid-induced Constipation for Hospital

      • 4.4.3 Market Size and Growth Rate of Opioid-induced Constipation for Others

    5 Market Analysis by Major Regions

    • 5.1 Europe Opioid-induced Constipation Production Analysis by Top Regions

    • 5.2 Europe Opioid-induced Constipation Consumption Analysis by Top Regions

    • 5.3 Europe Opioid-induced Constipation Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Opioid-induced Constipation Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Opioid-induced Constipation Production, Import, Consumption and Export Analysis

      • 5.3.3 France Opioid-induced Constipation Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Opioid-induced Constipation Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Opioid-induced Constipation Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Opioid-induced Constipation Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Opioid-induced Constipation Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Opioid-induced Constipation Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Opioid-induced Constipation Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioid-induced Constipation Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Opioid-induced Constipation Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Opioid-induced Constipation Production, Import, Consumption and Export Analysis

    6 Product Circulation of Opioid-induced Constipation Market among Top Countries

    • 6.1 Top 5 Export Countries in Opioid-induced Constipation Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Opioid-induced Constipation Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Opioid-induced Constipation Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Opioid-induced Constipation Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Opioid-induced Constipation Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Opioid-induced Constipation Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Opioid-induced Constipation Landscape Analysis

    • 7.1 Germany Opioid-induced Constipation Landscape Analysis by Major Types

    • 7.2 Germany Opioid-induced Constipation Landscape Analysis by Major End-Users

    8. UK Opioid-induced Constipation Landscape Analysis

    • 8.1 UK Opioid-induced Constipation Landscape Analysis by Major Types

    • 8.2 UK Opioid-induced Constipation Landscape Analysis by Major End-Users

    9. France Opioid-induced Constipation Landscape Analysis

    • 9.1 France Opioid-induced Constipation Landscape Analysis by Major Types

    • 9.2 France Opioid-induced Constipation Landscape Analysis by Major End-Users

    10. Italy Opioid-induced Constipation Landscape Analysis

    • 10.1 Italy Opioid-induced Constipation Landscape Analysis by Major Types

    • 10.2 Italy Opioid-induced Constipation Landscape Analysis by Major End-Users

    11. Spain Opioid-induced Constipation Landscape Analysis

    • 11.1 Spain Opioid-induced Constipation Landscape Analysis by Major Types

    • 11.2 Spain Opioid-induced Constipation Landscape Analysis by Major End-Users

    12. Poland Opioid-induced Constipation Landscape Analysis

    • 12.1 Poland Opioid-induced Constipation Landscape Analysis by Major Types

    • 12.2 Poland Opioid-induced Constipation Landscape Analysis by Major End-Users

    13. Russia Opioid-induced Constipation Landscape Analysis

    • 13.1 Russia Opioid-induced Constipation Landscape Analysis by Major Types

    • 13.2 Russia Opioid-induced Constipation Landscape Analysis by Major End-Users

    14. Switzerland Opioid-induced Constipation Landscape Analysis

    • 14.1 Switzerland Opioid-induced Constipation Landscape Analysis by Major Types

    • 14.2 Switzerland Opioid-induced Constipation Landscape Analysis by Major End-Users

    15. Turkey Opioid-induced Constipation Landscape Analysis

    • 15.1 Turkey Opioid-induced Constipation Landscape Analysis by Major Types

    • 15.2 Turkey Opioid-induced Constipation Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioid-induced Constipation Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioid-induced Constipation Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioid-induced Constipation Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioid-induced Constipation Landscape Analysis by Top Countries

      • 16.3.1 Denmark Opioid-induced Constipation Market Volume and Growth Rate

      • 16.3.2 Finland Opioid-induced Constipation Market Volume and Growth Rate

      • 16.3.3 Norway Opioid-induced Constipation Market Volume and Growth Rate

      • 16.3.4 Sweden Opioid-induced Constipation Market Volume and Growth Rate

      • 16.3.6 Iceland Opioid-induced Constipation Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Opioid-induced Constipation Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Opioid-induced Constipation Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Opioid-induced Constipation Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Opioid-induced Constipation Landscape Analysis by Top Countries

      • 17.3.1 Belgium Opioid-induced Constipation Market Volume and Growth Rate

      • 17.3.2 Netherlands Opioid-induced Constipation Market Volume and Growth Rate

      • 17.3.3 Luxembourg Opioid-induced Constipation Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Opioid-induced Constipation Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Opioid-induced Constipation Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Opioid-induced Constipation Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Opioid-induced Constipation Landscape Analysis by Top Countries

      • 18.3.1 Estonia Opioid-induced Constipation Market Volume and Growth Rate

      • 18.3.2 Latvia Opioid-induced Constipation Market Volume and Growth Rate

      • 18.3.3 Lithuania Opioid-induced Constipation Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Theravance

      • 19.1.1 Theravance Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Synergy Pharmaceuticals

      • 19.2.1 Synergy Pharmaceuticals Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Abbott

      • 19.3.1 Abbott Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 AstraZeneca

      • 19.4.1 AstraZeneca Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Cosmo Pharmaceuticals

      • 19.5.1 Cosmo Pharmaceuticals Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Progenics Pharmaceuticals

      • 19.6.1 Progenics Pharmaceuticals Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Mundipharma

      • 19.7.1 Mundipharma Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Boehringer Ingelheim

      • 19.8.1 Boehringer Ingelheim Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Sucampo

      • 19.9.1 Sucampo Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Ironwood Pharmaceuticals

      • 19.10.1 Ironwood Pharmaceuticals Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Takeda Pharmaceutical

      • 19.11.1 Takeda Pharmaceutical Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Pfizer

      • 19.12.1 Pfizer Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Shionogi

      • 19.13.1 Shionogi Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Daiichi Sankyo

      • 19.14.1 Daiichi Sankyo Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 GlaxoSmithKline

      • 19.15.1 GlaxoSmithKline Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 Johnson & Johnson

      • 19.16.1 Johnson & Johnson Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 Nektar Therapeutics

      • 19.17.1 Nektar Therapeutics Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 Valeant Pharmaceuticals International

      • 19.18.1 Valeant Pharmaceuticals International Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 Merck

      • 19.19.1 Merck Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    • 19.20 SLA Pharma

      • 19.20.1 SLA Pharma Company Profile and Development Status

      • 19.20.2 Market Performance

      • 19.20.3 Product and Service Introduction

    • 19.21 Daewoong

      • 19.21.1 Daewoong Company Profile and Development Status

      • 19.21.2 Market Performance

      • 19.21.3 Product and Service Introduction

    • 19.22 Bayer

      • 19.22.1 Bayer Company Profile and Development Status

      • 19.22.2 Market Performance

      • 19.22.3 Product and Service Introduction

    The List of Tables and Figures (Totals 77 Figures and 150 Tables)

    • Figure Product Picture

    • Figure Europe Opioid-induced Constipation Market Size and Growth Rate of Solid from 2014 to 2026

    • Figure Europe Opioid-induced Constipation Market Size and Growth Rate of Liquid from 2014 to 2026

    • Figure Europe Opioid-induced Constipation Market Size and Growth Rate of Drugstore from 2014 to 2026

    • Figure Europe Opioid-induced Constipation Market Size and Growth Rate of Hospital from 2014 to 2026

    • Figure Europe Opioid-induced Constipation Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

    • Figure UK Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

    • Figure France Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Opioid-induced Constipation Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Opioid-induced Constipation Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Opioid-induced Constipation

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Opioid-induced Constipation by Different Types from 2014 to 2026

    • Table Consumption Share of Opioid-induced Constipation by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Solid

    • Figure Market Size and Growth Rate of Liquid

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Opioid-induced Constipation by Different End-Users from 2014 to 2026

    • Table Consumption Share of Opioid-induced Constipation by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Drugstore

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Others

    • Table Europe Opioid-induced Constipation Production by Major Regions

    • Table Europe Opioid-induced Constipation Production Share by Major Regions

    • Figure Europe Opioid-induced Constipation Production Share by Major Countries and Regions in 2014

    • Table Europe Opioid-induced Constipation Consumption by Major Regions

    • Table Europe Opioid-induced Constipation Consumption Share by Major Regions

    • Table Germany Opioid-induced Constipation Production, Import, Consumption and Export Analysis

    • Table UK Opioid-induced Constipation Production, Import, Consumption and Export Analysis

    • Table France Opioid-induced Constipation Production, Import, Consumption and Export Analysis

    • Table Italy Opioid-induced Constipation Production, Import, Consumption and Export Analysis

    • Table Spain Opioid-induced Constipation Production, Import, Consumption and Export Analysis

    • Table Poland Opioid-induced Constipation Production, Import, Consumption and Export Analysis

    • Table Russia Opioid-induced Constipation Production, Import, Consumption and Export Analysis

    • Table Switzerland Opioid-induced Constipation Production, Import, Consumption and Export Analysis

    • Table Turkey Opioid-induced Constipation Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioid-induced Constipation Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Opioid-induced Constipation Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Opioid-induced Constipation Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Opioid-induced Constipation Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Opioid-induced Constipation Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Opioid-induced Constipation Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Opioid-induced Constipation Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Opioid-induced Constipation Consumption by Types from 2014 to 2026

    • Table Germany Opioid-induced Constipation Consumption Share by Types from 2014 to 2026

    • Table Germany Opioid-induced Constipation Consumption by End-Users from 2014 to 2026

    • Table Germany Opioid-induced Constipation Consumption Share by End-Users from 2014 to 2026

    • Table UK Opioid-induced Constipation Consumption by Types from 2014 to 2026

    • Table UK Opioid-induced Constipation Consumption Share by Types from 2014 to 2026

    • Table UK Opioid-induced Constipation Consumption by End-Users from 2014 to 2026

    • Table UK Opioid-induced Constipation Consumption Share by End-Users from 2014 to 2026

    • Table France Opioid-induced Constipation Consumption by Types from 2014 to 2026

    • Table France Opioid-induced Constipation Consumption Share by Types from 2014 to 2026

    • Table France Opioid-induced Constipation Consumption by End-Users from 2014 to 2026

    • Table France Opioid-induced Constipation Consumption Share by End-Users from 2014 to 2026

    • Table Italy Opioid-induced Constipation Consumption by Types from 2014 to 2026

    • Table Italy Opioid-induced Constipation Consumption Share by Types from 2014 to 2026

    • Table Italy Opioid-induced Constipation Consumption by End-Users from 2014 to 2026

    • Table Italy Opioid-induced Constipation Consumption Share by End-Users from 2014 to 2026

    • Table Spain Opioid-induced Constipation Consumption by Types from 2014 to 2026

    • Table Spain Opioid-induced Constipation Consumption Share by Types from 2014 to 2026

    • Table Spain Opioid-induced Constipation Consumption by End-Users from 2014 to 2026

    • Table Spain Opioid-induced Constipation Consumption Share by End-Users from 2014 to 2026

    • Table Poland Opioid-induced Constipation Consumption by Types from 2014 to 2026

    • Table Poland Opioid-induced Constipation Consumption Share by Types from 2014 to 2026

    • Table Poland Opioid-induced Constipation Consumption by End-Users from 2014 to 2026

    • Table Poland Opioid-induced Constipation Consumption Share by End-Users from 2014 to 2026

    • Table Russia Opioid-induced Constipation Consumption by Types from 2014 to 2026

    • Table Russia Opioid-induced Constipation Consumption Share by Types from 2014 to 2026

    • Table Russia Opioid-induced Constipation Consumption by End-Users from 2014 to 2026

    • Table Russia Opioid-induced Constipation Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Opioid-induced Constipation Consumption by Types from 2014 to 2026

    • Table Switzerland Opioid-induced Constipation Consumption Share by Types from 2014 to 2026

    • Table Switzerland Opioid-induced Constipation Consumption by End-Users from 2014 to 2026

    • Table Switzerland Opioid-induced Constipation Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Opioid-induced Constipation Consumption by Types from 2014 to 2026

    • Table Turkey Opioid-induced Constipation Consumption Share by Types from 2014 to 2026

    • Table Turkey Opioid-induced Constipation Consumption by End-Users from 2014 to 2026

    • Table Turkey Opioid-induced Constipation Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioid-induced Constipation Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioid-induced Constipation Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioid-induced Constipation Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioid-induced Constipation Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioid-induced Constipation Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Opioid-induced Constipation Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Opioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Opioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Opioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Opioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Opioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Opioid-induced Constipation Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Opioid-induced Constipation Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Opioid-induced Constipation Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Opioid-induced Constipation Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Opioid-induced Constipation Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Opioid-induced Constipation Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Opioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Opioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Opioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Opioid-induced Constipation Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Opioid-induced Constipation Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Opioid-induced Constipation Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Opioid-induced Constipation Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Opioid-induced Constipation Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Opioid-induced Constipation Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Opioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Opioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Opioid-induced Constipation Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Theravance

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Theravance

    • Figure Sales and Growth Rate Analysis of Theravance

    • Figure Revenue and Market Share Analysis of Theravance

    • Table Product and Service Introduction of Theravance

    • Table Company Profile and Development Status of Synergy Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Synergy Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Synergy Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Synergy Pharmaceuticals

    • Table Product and Service Introduction of Synergy Pharmaceuticals

    • Table Company Profile and Development Status of Abbott

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott

    • Figure Sales and Growth Rate Analysis of Abbott

    • Figure Revenue and Market Share Analysis of Abbott

    • Table Product and Service Introduction of Abbott

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Cosmo Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cosmo Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Cosmo Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Cosmo Pharmaceuticals

    • Table Product and Service Introduction of Cosmo Pharmaceuticals

    • Table Company Profile and Development Status of Progenics Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Progenics Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Progenics Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Progenics Pharmaceuticals

    • Table Product and Service Introduction of Progenics Pharmaceuticals

    • Table Company Profile and Development Status of Mundipharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mundipharma

    • Figure Sales and Growth Rate Analysis of Mundipharma

    • Figure Revenue and Market Share Analysis of Mundipharma

    • Table Product and Service Introduction of Mundipharma

    • Table Company Profile and Development Status of Boehringer Ingelheim

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim

    • Figure Sales and Growth Rate Analysis of Boehringer Ingelheim

    • Figure Revenue and Market Share Analysis of Boehringer Ingelheim

    • Table Product and Service Introduction of Boehringer Ingelheim

    • Table Company Profile and Development Status of Sucampo

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sucampo

    • Figure Sales and Growth Rate Analysis of Sucampo

    • Figure Revenue and Market Share Analysis of Sucampo

    • Table Product and Service Introduction of Sucampo

    • Table Company Profile and Development Status of Ironwood Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ironwood Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Ironwood Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Ironwood Pharmaceuticals

    • Table Product and Service Introduction of Ironwood Pharmaceuticals

    • Table Company Profile and Development Status of Takeda Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceutical

    • Table Product and Service Introduction of Takeda Pharmaceutical

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Shionogi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shionogi

    • Figure Sales and Growth Rate Analysis of Shionogi

    • Figure Revenue and Market Share Analysis of Shionogi

    • Table Product and Service Introduction of Shionogi

    • Table Company Profile and Development Status of Daiichi Sankyo

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo

    • Figure Sales and Growth Rate Analysis of Daiichi Sankyo

    • Figure Revenue and Market Share Analysis of Daiichi Sankyo

    • Table Product and Service Introduction of Daiichi Sankyo

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of Nektar Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nektar Therapeutics

    • Figure Sales and Growth Rate Analysis of Nektar Therapeutics

    • Figure Revenue and Market Share Analysis of Nektar Therapeutics

    • Table Product and Service Introduction of Nektar Therapeutics

    • Table Company Profile and Development Status of Valeant Pharmaceuticals International

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valeant Pharmaceuticals International

    • Figure Sales and Growth Rate Analysis of Valeant Pharmaceuticals International

    • Figure Revenue and Market Share Analysis of Valeant Pharmaceuticals International

    • Table Product and Service Introduction of Valeant Pharmaceuticals International

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of SLA Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SLA Pharma

    • Figure Sales and Growth Rate Analysis of SLA Pharma

    • Figure Revenue and Market Share Analysis of SLA Pharma

    • Table Product and Service Introduction of SLA Pharma

    • Table Company Profile and Development Status of Daewoong

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daewoong

    • Figure Sales and Growth Rate Analysis of Daewoong

    • Figure Revenue and Market Share Analysis of Daewoong

    • Table Product and Service Introduction of Daewoong

    • Table Company Profile and Development Status of Bayer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US